Gene Therapy Market Size is Projected to Be Worth US$ 9.5 Billion by 2027

The latest research study "Gene Therapy Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027" by IMARC Group, finds that the global gene therapy market reached a value of US$ 3.77 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 9.5 Billion by 2027 exhibiting a CAGR of 15.60% during 2022-2027.

By adjusting the expression of defective genes or changing the biological characteristics of living cells, gene therapy is an approach for both preventing and curing disease. To treat illness and strengthen the body's resistance to numerous diseases, it either introduces a new gene or replaces the disease-causing gene. Numerous disorders, such as cancer, diabetes, haemophilia, cystic fibrosis, heart disease, and acquired immunodeficiency syndrome, are currently treated with a variety of gene therapy products, such as viral vectors, bacterial vectors, and patient-derived cellular gene therapies (AIDS).

Download a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/gene-therapy-market/requestsample

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Gene Therapy Market Trends and Drivers:

The market is primarily driven by the growing prevalence of inherited diseases and acquired disorders. In addition, the rising incidences of genetic disorders, such as muscular dystrophy and cystic fibrosis, in children and young adults represent another major growth-inducing factor.

Besides this, scientists and researchers are developing new gene therapies to treat a broad range of chronic pain conditions, such as lower back pain and rare neuropathic pain disorders. This, coupled with the introduction of favorable government initiatives to develop effective gene therapies to treat cancer, is positively influencing the market growth.

For instance, in March 2021, the United States Food and Drug Administration (FDA) approved Abecma, a cell-based gene therapy to treat patients with multiple myeloma. Moreover, the leading market players are engaging in mergers and acquisitions (M&As) and partnerships to strengthen their foothold in the market, which is also creating a favorable market outlook across the globe.

Global Gene Therapy Market 2022-2027 Analysis and Segmentation:

Competitive Landscape:

The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.

Abeona Therapeutics Inc., Adaptimmune Therapeutics plc, Adverum Biotechnologies Inc., Amgen Inc., Astellas Pharma Inc., Biogen Inc., Bluebird Bio Inc., Mustang Bio Inc. (Fortress Biotech Inc.), Novartis AG, Orchard Therapeutics plc, UniQure N.V. and Voyager Therapeutics Inc.

Inquire Before Buying : https://www.imarcgroup.com/request?type=report&id=5026&flag=F

The report has segmented the market on the basis of region, gene type, vector type, delivery method and application

Breakup by Gene Type:
• Antigen
• Cytokine
• Tumor Suppressor
• Suicide Gene
• Deficiency
• Growth Factors
• Receptors
• Others

Breakup by Vector Type:
• Viral Vector
o Adenoviruses
o Lentiviruses
o Retroviruses
o Adeno-Associated Virus
o Herpes Simplex Virus
o Poxvirus
o Vaccinia Virus
o Others
• Non-Viral Techniques
o Naked and Plasmid Vectors
o Gene Gun
o Electroporation
o Lipofection
o Others

Breakup by Delivery Method:
• In-Vivo Gene Therapy
• Ex-Vivo Gene Therapy

Breakup by Application:
• Oncological Disorders
• Rare Diseases
• Cardiovascular Diseases
• Neurological Disorders
• Infectious Disease
• Others

Breakup by Region:
• North America: (United States, Canada)
• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
• Latin America: (Brazil, Mexico, Others)
• Middle East and Africa

Ask Analyst for Customization and Explore Full Report with TOC & List of Figure: https://www.imarcgroup.com/gene-therapy-market

If you want latest primary and secondary data (2022-2027) with Cost Module, Business Strategy, Distribution Channel, etc. Click request free sample report, published report will be delivered to you in PDF format via email within 24 to 48 hours of receiving full payment.

Key highlights of the report:
• Market Performance (2016-2021)
• Market Outlook (2022- 2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Contact Us:

IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA - Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.